Annotation Detail for SAMD9L
Basic Information
Top
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of SAMD9L protein | affects expression | 20106945
|
| D016572 |
Cyclosporine |
Cyclosporine results in increased expression of SAMD9L mRNA | increases expression | 20106945
|
| D015215 |
Zidovudine |
[Zidovudine co-treated with IFNA1 protein] results in increased expression of SAMD9L mRNA | affects cotreatment|increases expression | 20370541
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000163 |
Acquired Immunodeficiency Syndrome |
|
Zidovudine |
5.48 | 9612607 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
1.99 | 12907637 21507988 12619106 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.82 | 12371664 |
| MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.24 | 19486331 |
| MESH:D004362 |
Drug Toxicity |
|
Zidovudine |
4.33 | 15040536 |
| MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
9.63 | 19224547 |
| MESH:D005234 |
Fatty Liver |
|
Zidovudine |
9.63 | 18299183 |
| MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.79 | 12639820 12168785 |
| MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.96 | 8708960 |
| MESH:D006402 |
Hematologic Diseases |
|
Zidovudine |
5.24 | 12579204 |
| MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
5.16 | 15720958 |
| MESH:D015658 |
HIV Infections |
|
Zidovudine |
3.69 | 11698656 17358032 11363243 11141242 20032539 |
| MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.23 | 10903974 |
| MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
5.31 | 15604871 |
| MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.56 | 8314463 10903974 18776723 |
| MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
8.88 | 12371664 |
| MESH:D007680 |
Kidney Neoplasms |
|
Zidovudine |
8.88 | 12579204 |
| MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Zidovudine |
4.90 | 20370541 |
| MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
2.47 | 18177683 2125692 15890375 9163691 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
2.99 | 8603461 |
| MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
2.85 | 14755239 |
| MESH:D008175 |
Lung Neoplasms |
|
Zidovudine |
2.85 | 18800350 |
| MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.65 | 16801185 |
| MESH:D048629 |
Micronuclei, Chromosome-Defective |
|
Zidovudine |
6.71 | 17358032 |
| MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
5.31 | 17954296 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.70 | 18481113 19348381 |
| MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.64 | 12371664 |
| MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.34 | 16882103 |
| MESH:D013274 |
Stomach Neoplasms |
|
Zidovudine |
2.48 | 17696246 |
| MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.85 | 1336536 |
| MESH:D014625 |
Vaginal Neoplasms |
|
Zidovudine |
5.41 | 12579204 |
| MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
5.31 | 17120751 |
Related Pathway Information